Title

Efficacy and Safety Results of Guselkumab in Patients With Active Psoriatic Arthritis Over 56 Weeks From a Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study

Document Type

Abstract

Publication Date

October 2017

Department

Dermatology

Share

COinS